Multimorbidity patterns in adult day health center clients with dementia: a latent class analysis
June 22, 2022 Continue reading
Resource Type
Deprescribing Education vs Usual Care for Patients with Cognitive Impairment and Primary Care Clinicians: The OPTIMIZE Pragmatic Cluster Randomized Trial
May 2022 – In Grand Rounds 27, the NIA IMPACT Collaboratory collaborated with the US Deprescribing Research Network (USDeN) to present on the OPTIMIZE Pragmatic Cluster Randomized Trial.
Speakers
Elizabeth Bayliss, MD, MSPH
Senior Investigator
Institute for Health Research
Kaiser Permanente Colorado
Professor of Family Medicine
University of Colorado School of Medicine
Cynthia Boyd, MD, MPH
Professor
Medicine, Epidemiology, and Health Policy & Management
Johns Hopkins University School of Medicine
Learning Objectives
- Understand the approach used to conduct a pragmatic trial of deprescribing education in primary care
- Describe cognitively impaired populations that may benefit from deprescribing education in primary care
- Discuss potential adaptations of a deprescribing education intervention in a large health system
Podcast
Podcast Transcript: Download the transcript here.
Embedding Health Equity in a Cluster Randomized Trial of an Advance Care Planning Intervention
April 2022 – In Grand Rounds 26, Kimberly S. Johnson, MD, professor of medicine and director of the Duke Center for Research to Advance Healthcare Equity at Duke Health, shares her experience in leading an embedded pragmatic clinical trial focused on health equity in advance care planning.
Speaker
Kimberly S. Johnson, MD
Professor of Medicine
Director of the Duke Center for Research to Advance Healthcare Equity, Duke Health
Learning Objectives
- Describe current gaps and challenges in equitable conduct and reporting of research findings.
- Describe strategies to promote diversity, equity, and inclusion throughout the research process.
- Identify at least one opportunity to embed processes to increase enrollment of underrepresented populations in your work and promote equitable access to your research studies.
